Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2020 1
2021 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Sabrija
Page 1
Alzheimer's disease drug development pipeline: 2023.
Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Cummings J, et al. Alzheimers Dement (N Y). 2023 May 25;9(2):e12385. doi: 10.1002/trc2.12385. eCollection 2023 Apr-Jun. Alzheimers Dement (N Y). 2023. PMID: 37251912 Free PMC article. Review.
We created an automated computational database platform to search, archive, organize, and analyze the derived data. The Common Alzheimer's Disease Research Ontology (CADRO) was used to identify treatment targets and drug mechanisms. ...
We created an automated computational database platform to search, archive, organize, and analyze the derived data. The Common Alzheimer's D …
Alzheimer's disease drug development pipeline: 2022.
Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, Taghva K. Cummings J, et al. Alzheimers Dement (N Y). 2022 May 4;8(1):e12295. doi: 10.1002/trc2.12295. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35516416 Free PMC article. Review.
We used artificial intelligence (AI) and machine learning (ML) approaches to ensure comprehensive detection and characterization of trials and drugs in development. We use the Common Alzheimer's Disease Research Ontology (CADRO) to classify drug targets and mechanisms of a …
We used artificial intelligence (AI) and machine learning (ML) approaches to ensure comprehensive detection and characterization of trials a …
Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification.
Cummings JL, Osse AML, Kinney JW. Cummings JL, et al. Drugs. 2023 Oct;83(15):1387-1408. doi: 10.1007/s40265-023-01938-w. Epub 2023 Sep 20. Drugs. 2023. PMID: 37728864 Free PMC article. Review.
Most of the target processes identified in the Common Alzheimer's Disease Research Ontology (CADRO) are represented by novel agents in trials. Inflammation and synaptic plasticity/neuroprotection are the CADRO categories with the largest number of novel candidate th …
Most of the target processes identified in the Common Alzheimer's Disease Research Ontology (CADRO) are represented by novel agents i …
Alzheimer's disease drug development pipeline: 2021.
Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Cummings J, et al. Alzheimers Dement (N Y). 2021 May 25;7(1):e12179. doi: 10.1002/trc2.12179. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 34095440 Free PMC article.
Alzheimer's disease drug development pipeline: 2020.
Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Cummings J, et al. Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050. doi: 10.1002/trc2.12050. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 32695874 Free PMC article.
We use the Common Alzheimer's and Related Dementias Research Ontology (CADRO) to classify treatment targets and mechanisms of action. We review our annual pipeline reports for the past 5 years to provide longitudinal insight into clinical trials and drug development for AD …
We use the Common Alzheimer's and Related Dementias Research Ontology (CADRO) to classify treatment targets and mechanisms of action. …
[Alzheimer's disease-Which substances are at present in phase III studies?].
Hager K. Hager K. Nervenarzt. 2022 Oct;93(10):1028-1034. doi: 10.1007/s00115-022-01275-5. Epub 2022 Mar 14. Nervenarzt. 2022. PMID: 35288774 Free PMC article. German.
The mode of action of the different substances was classified according to the Common Alzheimer's Disease Research Ontology (CADRO). RESULTS: With the applied search criteria 53 studies were found, 32 studies with 25 substances dealt with cognition, which was demonstrated …
The mode of action of the different substances was classified according to the Common Alzheimer's Disease Research Ontology (CADRO). …
Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project.
Refolo LM, Snyder H, Liggins C, Ryan L, Silverberg N, Petanceska S, Carrillo MC. Refolo LM, et al. Alzheimers Dement. 2012 Jul;8(4):372-5. doi: 10.1016/j.jalz.2012.05.2115. Alzheimers Dement. 2012. PMID: 22748941
To this end, the National Institute on Aging at the National Institutes of Health and the Alzheimer's Association developed the Common Alzheimer's Disease Research Ontology (CADRO) as a dynamic portfolio analysis tool that can be used by funding agencies worldwide for stra …
To this end, the National Institute on Aging at the National Institutes of Health and the Alzheimer's Association developed the Common Alzhe …
11 results